Ajanta Pharma has informed that pursuant to Regulation 29 of the Listing Regulations, a meeting of the Board of Directors of the Company will be held on Tuesday, 10th May 2022 to consider Audited Financial Results (consolidated & standalone) of the Company for the quarter and year ended 31st March 2022; Audited Financial Statements (consolidated & standalone) for the year ended 31st March 2022 and issue of bonus shares subject to approval by the shareholders of the Company.
The above information is a part of company’s filings submitted to BSE.
